This press release hides some good news. I understand there was some talk about a second phase II trial for Proellex to evaluate alternative dosing schedules. Looks like they're going straight to phase III.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.